62
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Solusomes (novel soluplus® enriched nano-vesicular carriers) for improving the oral bioavailability of Candesartan cilexetil

, , , &
Pages 13-24 | Received 30 Aug 2023, Accepted 26 Nov 2023, Published online: 06 Dec 2023

References

  • Abd-Elal RM, Shamma RN, Rashed HM, Bendas ER. 2016. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Drug Deliv. 23(9):3374–3386. doi: 10.1080/10717544.2016.1183721.
  • Abd-Elal RMA, Essawy AM, Salem MA, Elsayed M, Khalil MG, Abdelhakeem E, Ali NA, Tawfik MA. 2023. Formulation, optimization, in-vivo biodistribution studies and histopathological safety assessment of duloxetine HCl-loaded ultra-elastic nanovesicles for antidepressant effect after intranasal and transdermal delivery. Int J Pharm X. 6:100194. doi: 10.1016/j.ijpx.2023.100194.
  • AboulFotouh K, Allam AA, El-Badry M, El-Sayed AM. 2017. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil. Eur J Pharm Sci. 109:503–513. doi: 10.1016/j.ejps.2017.09.001.
  • AboulFotouh K, Allam AA, El-Badry M, El-Sayed AM. 2019. A self-nanoemulsifying drug delivery system for enhancing the oral bioavailability of Candesartan cilexetil: ex vivo and in vivo evaluation. J Pharm Sci. 108(11):3599–3608. doi: 10.1016/j.xphs.2019.07.004.
  • Aboumanei MH, Abdelbary AA, Ibrahim IT, Tadros MI, El-Kolaly MT. 2018. Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: in vitro characterization, molecular docking, 125I-radiolabeling and in vivo biodistribution studies. Int J Pharm. 545(1–2):240–253. doi: 10.1016/j.ijpharm.2018.05.010.
  • AbuElfadl A, Boughdady M, Meshali M. 2021. New Peceol™/Span™ 60 niosomes coated with chitosan for Candesartan Cilexetil: perspective increase in absolute bioavailability in rats. Int J Nanomedicine. 16:5581–5601. doi: 10.2147/IJN.S324171.
  • Adireddy V, Bimireddy BPK, Pulipati CR, Ponneri V. 2017. A simple and rapid determination of candesartan in human plasma by LC- MS/MS. Int J Pharm. 7:47–54.
  • Alsheyyab R, Obaidat R, Tall YA, Abuhuwaij R, Ghanma R, Ailabouni A, Mashaqbeh H, Al-Haj S. 2019. Solubility enhancement of nimodipine through preparation of Soluplus® dispersions. J Appl Pharm Sci. 9:30–37. doi: 10.7324/JAPS.2019.90905.
  • Ammar HO, Tadros MI, Salama NM, Ghoneim AM. 2020. Ethosome-derived invasomes as a potential transdermal delivery system for vardenafil hydrochloride: development, optimization and application of physiologically based pharmacokinetic modeling in adults and geriatrics. Int J Nanomedicine. 15:5671–5685. doi: 10.2147/IJN.S261764.
  • Anjani QK, Sabri AHB, Moreno-Castellanos N, Utomo E, Cárcamo-Martínez Á, Domínguez-Robles J, Wardoyo LAH, Donnelly RF. 2022. Soluplus®-based dissolving microarray patches loaded with colchicine: towards a minimally invasive treatment and management of gout. Biomater Sci. 10(20):5838–5855. doi: 10.1039/d2bm01068b.
  • Asadi A, Pourfattah F, Szilágyi IM, Afrand M, Żyła G, Ahn HS, Wongwises S, Nguyen HM, Arabkoohsar A, Mahian O. 2019. Effect of sonication characteristics on stability, thermophysical properties, and heat transfer of nanofluids: a comprehensive review. Ultrason Sonochem. 58:104701. doi: 10.1016/j.ultsonch.2019.104701.
  • Bonde GV, Ajmal G, Yadav SK, Mittal P, Singh J, Bakde BV, Mishra B. 2020. Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): optimisation and in-vitro characterization. Colloids Surf B Biointerfaces. 185:110611. doi: 10.1016/j.colsurfb.2019.110611.
  • Bruni G, Maggi L, Tammaro L, Lorenzo RD, Friuli V, D Aniello S, Maietta M, Berbenni V, Milanese C, Girella A, et al. 2016. Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine. Int J Pharm. 511(1):190–197. doi: 10.1016/j.ijpharm.2016.07.011.
  • Chen C, Han D, Cai C, Tang X. 2009. An overview of liposome lyophilisation and its future potential. J Control Release. 142(3):299–311. doi: 10.1016/j.jconrel.2009.10.024.
  • Daeihamed M, Dadashzadeh S, Haeri A, Akhlaghi MF. 2017. Potential of liposomes for enhancement of oral drug absorption. Curr Drug Deliv. 14(2):289–303. doi: 10.2174/1567201813666160115125756.
  • El Taweel MM, Tawfik MA, Soliman K, Khattab MS, Farag MM. 2023. Tailoring of topically applied curcumin loaded pro-novasomes for skin cancer treatment: in-vitro characterization, statistical optimization and histopathological assessment of subcutaneous Ehrlich carcinoma mice model. J Drug Delivery Sci Technol. 88:104957. doi: 10.1016/j.jddst.2023.104957.
  • Elsharkawy FM, Amin MM, Shamsel-Din HA, Ibrahim W, Ibrahim AB, Sayed S. 2023. Self-assembling lecithin-based mixed polymeric micelles for nose to brain delivery of clozapine: in-vivo assessment of drug efficacy via radiobiological evaluation. Int J Nanomed. 18:1577–1595. doi: 10.2147/IJN.S403707.
  • Ertürk AS, Gürbüz MU, Tülü M. 2017. The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil. Pharm Dev Technol. 22(1):111–121. doi: 10.1080/10837450.2016.1219372.
  • Fahmy UA. 2015. Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation. Drug Des Devel Ther. 9:6129–6137. doi: 10.2147/DDDT.S94615.
  • Fathi HA, Yousry C, Elsabahy M, El-Badry M, El Gazayerly ON. 2023. Effective loading of incompatible drugs into nanosized vesicles: a strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings. Int J Pharm. 636:122852. doi: 10.1016/j.ijpharm.2023.122852.
  • Fatouh AM, Elshafeey AH, Abdelbary A. 2017. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Drug Des Devel Ther. 11:1815–1825. doi: 10.2147/DDDT.S102500.
  • Gaonkar S, Gaud RS. 2014. Improved wetting for improved solubility and dissolution of candesartan cilexetil, comparative study of surfactant and modified surfactant in varying ratios. iosrphr. 04(12):01–09. doi: 10.9790/3013-040120109.
  • Gurunath S, Nanjwade BK, Patila PA. 2014. Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs. Saudi Pharm J. 22(3):246–257. doi: 10.1016/j.jsps.2013.03.006.
  • Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A. 2014. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high-pressure homogenization techniques. Colloids Surf B Biointerfaces. 122:591–600. doi: 10.1016/j.colsurfb.2014.07.037.
  • Jeong HC, Seo YH, Gu N, Rhee MY, Shin KH. 2021. Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS. Transl Clin Pharmacol. 29(4):226–238. doi: 10.12793/tcp.2021.29.e21.
  • Jesson G, Brisander M, Andersson P, Demirbüker M, Derand H, Lennernäs H, Malmsten M. 2014. Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors. Pharm Res. 31(3):694–705. doi: 10.1007/s11095-013-1191-4.
  • Jia S, Ning S, Leng Y, Jing Q, Xu Z, Ren F. 2022. Stabilizing effect of soluplus on erlotinib metastable crystal form in microparticles and amorphous solid dispersions. Polymers. 14(6):1241. doi: 10.3390/polym14061241.
  • Jiang S, Mou Y, He H, Yang D, Qin L, Zhang F, Zhang P. 2019. Preparation and evaluation of self-assembly Soluplus®-sodium cholate-phospholipid ternary mixed micelles of docetaxel. Drug Dev Ind Pharm. 45(11):1788–1798. doi: 10.1080/03639045.2019.1660365.
  • Katti V, Kadam A, Honmane S, Patil S, Patil S, Bhamare K. 2014. Improvement of solubility and dissolution rate of candesartan cilexetil by solid dispersion in polyvinyl pyrrolidone. Int J Pharm Sci Res. 5:1550–1556. doi: 10.13040/IJPSR.0975-8232.5(4).1550-56.
  • Krupa A, Cantin O, Strach B, Wyska E, Tabor Z, Siepmann J, Wróbel A, Jachowicz R. 2017. In vitro and in vivo behavior of ground tadalafil hot-melt extrudates: how the carrier material can effectively assure rapid or controlled drug release. Int J Pharm. 528(1-2):498–510. doi: 10.1016/j.ijpharm.2017.05.057.
  • Linn M, Collnot EM, Djuric D, Hempel K, Fabian E, Kolter K, Lehr CM. 2012. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 45(3):336–343. doi: 10.1016/j.ejps.2011.11.025.
  • Mosallam S, Sheta NM, Elshafeey AH, Abdelbary AA. 2021. Fabrication of highly deformable bilosomes for enhancing the topical delivery of terconazole: in vitro characterization, microbiological evaluation, and in vivo skin deposition study. AAPS PharmSciTech. 22(2):74. doi: 10.1208/s12249-021-01924-z.
  • Nekkanti V, Karatgi P, Prabhu R, Pillai R. 2010. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech. 11(1):9–17. doi: 10.1208/s12249-009-9347-6.
  • Nekkanti V, Pillai R, Venkateshwarlu V, Harisudhan T. 2009. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles. Pharm Dev Technol. 14(3):290–298. doi: 10.1080/10837450802585278.
  • Piazzini V, Landucci E, Urru M, Chiarugi A, Pellegrini-Giampietro DE, Bilia AR, Bergonzi MC. 2020. Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: in vitro and in vivo evaluation. Int J Pharm. 583:119361. doi: 10.1016/j.ijpharm.2020.119361.
  • Pore Y, Mane M, Mangrule V, Chopade A, Gajare P. 2018. Preparation, characterization, and evaluation of anti-inflammatory activity of etoricoxib loaded soluplus® nanocomposites. Int J App Pharm. 10(6):268. doi: 10.22159/ijap.2018v10i6.26042.
  • Poudel S, Kim DW. 2021. Developing pH-modulated spray dried amorphous solid dispersion of candesartan cilexetil with enhanced in vitro and in vivo performance. Pharmaceutics. 13(4):497. doi: 10.3390/pharmaceutics13040497.
  • Salih OS, Hamoddi ZM, Taher S. 2020. Development and characterization of controlled release tablets of candesartan cilexetil/β ‑ cyclodextrin inclusion complex. ijddt. 10(02):273–283. doi: 10.25258/ijddt.10.2.15.
  • Sezgin-Bayindir Z, Antep MN, Yuksel N. 2015. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug. AAPS PharmSciTech. 16(1):108–117. doi: 10.1208/s12249-014-0213-9.
  • Shah R, Eldridge D, Palombo E, Harding I. 2014. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci. 25:59–75.
  • Shamma RN, Basha M. 2013. Soluplus®: a novel polymeric solubilizer for optimization of Carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol. 237:406–414. doi: 10.1016/j.powtec.2012.12.038.
  • Shamma RN, Elsayed I. 2013. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 23(3):244–254. doi: 10.3109/08982104.2013.801489.
  • Shukla J, Jani GK, Omri A. 2016. Formulation and evaluation of oral self microemulsifying drug delivery system of candesartan cilexetil. Int J Pharm Pharm Sci. 8:238–243.
  • Singh J, Mittal P, Bonde GV, Ajmal G, Mishra B. 2018. Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment. Artif Cells Nanomed Biotechnol. 46(Suppl 3):S546–S555. doi: 10.1080/21691401.2018.1501379.
  • Sravya M, Deveswaran R, Bharath S, Basavaraj BV, Madhavan V. 2013. Development of orodispersible tablets of candesartan cilexetil- β -cyclodextrin complex. J Pharm. 2013:583536–583513. doi: 10.1155/2013/583536.
  • Takayama R, Inoue Y, Murata I, Kanamoto I. 2020. Characterization of nanoparticles using DSPE-PEG2000 and soluplus. Colloids Interfaces. 4(3):28. doi: 10.3390/colloids4030028.
  • Tawfik MA, Eltaweel MM, Farag MM, Shamsel-Din HA, Ibrahim AB. 2023. Sonophoresis-assisted transdermal delivery of antimigraine-loaded nanolipomers: radio-tracking, histopathological assessment and in-vivo biodistribution study. Int J Pharm. 644:123338. doi: 10.1016/j.ijpharm.2023.123338.
  • Tawfik MA, Eltaweel MM, Fatouh AM, Shamsel-Din HA, Ibrahim AB. 2023. Brain targeting of zolmitriptan via transdermal terpesomes: statistical optimization and in vivo biodistribution study by 99mTc radiolabeling technique. Drug Deliv Transl Res. 13(12):3059–3076. doi: 10.1007/s13346-023-01373-0.
  • Tawfik MA, Mohamed MI, Tadros MI, El-Helaly SN. 2021. Low-frequency sonophoresis as an active approach to potentiate the transdermal delivery of agomelatine-loaded novasomes: design, optimization, and pharmacokinetic profiling in rabbits. AAPS PharmSciTech. 22(8):261. doi: 10.1208/s12249-021-02147-y.
  • Tawfik MA, Tadros MI, Mohamed MI, El-Helaly SN. 2020. Low-frequency versus high-frequency ultrasound-mediated transdermal delivery of agomelatine-loaded invasomes: development, optimization and in-vivo pharmacokinetic assessment. Int J Nanomed. 15:8893–8910. doi: 10.2147/IJN.S283911.
  • Tawfik MA, Tadros MI, Mohamed MI. 2018. Lipomers (lipid-polymer hybrid particles) of vardenafil hydrochloride: a promising dual platform for modifying the drug release rate and enhancing its oral bioavailability. AAPS PharmSciTech. 19(8):3650–3660. doi: 10.1208/s12249-018-1191-0.
  • Tawfik MA, Tadros MI, Mohamed MI. 2019. Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of vardenafil hydrochloride. Pharm Dev Technol. 24(3):293–302. doi: 10.1080/10837450.2018.1472611.
  • Zeng YC, Li S, Liu C, Gong T, Sun X, Fu Y, Zhang ZR. 2017. Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo. Acta Pharmacol Sin. 38(3):424–433. doi: 10.1038/aps.2016.126.
  • Zhang Z, Gao F, Bu H, Xiao J, Li Y. 2011. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine. 8(5):740–747. doi: 10.1016/j.nano.2011.08.016.
  • Zhong Y, Jing G, Tian B, Huang H, Zhang Y, Gou J, Tang X, He H, Wang Y. 2016. Supersaturation induced by Itraconazole/Soluplus® micelles provided high GI absorption in vivo. Asian J Pharm Sci. 11(2):255–264. doi: 10.1016/j.ajps.2015.07.001.
  • Zulal N, Lakshmi P. 2015. Enhancement of solubility and bioavailability of candesartan cilexetil using natural p-glycoprotein inhibitors. Trop J Pharm Res. 14(1):21–26. doi: 10.4314/tjpr.v14i1.4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.